This study targeted 11 opioid analgesics with a high potential for dependence and abuse—morphine, fentanyl, oxycodone, methadone, pethidine, codeine, tramadol, pentazocine, buprenorphine, naloxone, and O-desmethyltramadol—to develop a rapid, simple, and sensitive screening method for whole blood analysis. A pretreatment procedure was established that combines dried blood spot (DBS) extraction with solid-phase dispersive extraction (SPDE) cleanup using Captiva ND Lipids to remove phospholipids effectively. Analysis was performed by liquid chromatography coupled with time-of-flight mass spectrometry (LC/TOF-MS). The combined DBS–SPDE approach improved the precision of the recovery tests, and peaks likely originating from phospholipids observed with DBS extraction alone disappeared, indicating efficient phospholipid removal. The limits of detection and quantification for the 11 opioids were 0.02–0.05 ng/mL and 0.05–0.1 ng/mL, respectively. Validation results showed good trueness for most opioids (83.6–115.7 %), although morphine, buprenorphine, and naloxone exhibited lower values (24.2–49.0 %). Precision was satisfactory, with repeatability below 15 % and intermediate precision below 20 % for most analytes, except for morphine and buprenorphine, which showed slightly higher variability. These findings demonstrate that the proposed LC/TOF-MS method achieves sufficient sensitivity and reproducibility for screening purposes. The method offers a practical tool for identifying opioids and monitoring therapeutic drug levels in forensic and clinical applications.
扫码关注我们
求助内容:
应助结果提醒方式:
